Lodosyn
- RxCUI
- 203437
- RxNorm name
- Lodosyn
- Term type
- BN
- Status
- Active
- Updated
- 2026-11-06 11:40:06
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- YES
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| carbidopa | 2019 |
Source Vocabulary Codes#
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| FDASPL | N0000175754 | Aromatic Amino Acid Decarboxylation Inhibitor | EPC | has_epc | carbidopa |
| FDASPL | N0000175755 | DOPA Decarboxylase Inhibitors | MOA | has_moa | carbidopa |
| MEDRT | D002230 | Carbidopa | CHEM | has_ingredient | carbidopa |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | carbidopa |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | carbidopa |
| MEDRT | D008545 | Melanoma | DISEASE | ci_with | carbidopa |
| MEDRT | D010300 | Parkinson Disease | DISEASE | may_treat | carbidopa |
| MEDRT | N0000000203 | Dopamine Receptor Interactions | MOA | has_moa | carbidopa |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | carbidopa |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | carbidopa |
| MEDRT | N0000009183 | Increased Central Nervous System Dopamine Activity | PE | has_pe | carbidopa |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | BN_CARDINALITY | single |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| SOURCES | Source | Multum MediSource Lexicon |